AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2025
Jan 6, 2025
30610_dirs_2025-01-06_05d33601-747c-4684-8816-7737e3cef5fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-01-03
Reporting Person: Mock James M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-03 | Common Stock | M | 1453 | — | Acquired | 12519 | Direct |
| 2025-01-03 | Common Stock | F | 780 | $42.00 | Disposed | 11739 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | Restricted Stock Units | $ | M | 1453 | Disposed | Common Stock (1453) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
More from Moderna, Inc.
Call Transcript
2026
Jun 9
Call Transcript
2026
Jun 2
Call Transcript
2026
May 28
Call Transcript
2026
May 19
Call Transcript
2026
May 12
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Call Transcript
2026
May 6
Call Transcript
2026
May 1
Call Transcript
2026
Mar 10
Director's Dealing
2026
Mar 3